Clinical Application of Adaptive Optics Retinal Imaging Incubator Meeting
Events
Clinical Application of Adaptive Optics Retinal Imaging Incubator Meeting
6-8 November 2012
OSA Headquarters
Washington, DC, USA
Hosted by: Matthew McMahon, National Eye Institute; Joseph Carroll, Medical College of Wisconsin; Jacque Duncan, University of California San Francisco; and David Williams, University of Rochester
Sponsorship Level
Platinum
Silver
Bronze
Topics Discussed
Featured Topics
Confirmed Attendees
Topics Discussed
The overall goal of this Incubator Meeting was to chart the course forward for adaptive optics (AO) retinal imaging systems, from the perspective of clinical research, intervention monitoring, diagnosis, and clinical management. This meeting aimed to bring together leading researchers, engineers, and clinicians from academia, industry, and government to meet and discuss advances, challenges and opportunities, and future trends in research, development, and applications. The meeting topics were broken into 3 major themes: Imaging Systems, Image Metrics, and Achieving Clinical Utility.
View the program book, including agenda, discussion topics and host and attendee biographies
Featured Topics
- Imaging Systems
- What are the minimum requirements for systems and the data they generate?
- What hurdles need to be overcome to make AO imaging sufficiently accessible?
- How can AO images be integrated into other imaging modalities to maximize the value of the data?
- Image Metrics
- What metrics can/should be extractable from the data (define a minimum set), within the areas of photoreceptors, blood vessels, nerve fiber, and optic disc.
- What advances need to be made and what data needs to be generated to drive acceptance of AO imaging as a regulatory endpoint?
- Achieving Clinical Utility
- What are the most promising potential clinical applications of AO technology, including use for diagnosis or treatment decisions, for which AO imaging may play a role or provide unique insight?
- What needs to be done to enable the use of AO imaging to accelerate the development of therapies (including, but not limited to, pre-clinical and multi-center clinical studies)?
Confirmed Attendees Include
| Lloyd Paul Aiello, Joslin Diabetes Center, Harvard Medical School |
| Benjamin Backus, SUNY College of Optometry at New York City |
| Samuel Barone, Food and Drug Administration |
| Paul Bierden, Boston Micromachines Corporation |
| David Birch, Retina Foundation of the Southwest |
| Barb Blodi, University of Wisconsin |
| Stephen Burns, Indiana University |
| Melanie Campbell, University of Waterloo |
| Joseph Carroll, Medical College of Wisconsin |
| Nicolas Chateau, imagine eyes |
| Emily Chew, National Eye Institute |
| Judith Chiostri, Foundation Fighting Blindness |
| Mina Chung, University of Rochester |
| Thomas Connor, Medical College of Wisconsin |
| Robert Cooper, Marquette University |
| Steven Cornelissen, Boston Micromachines Corporation |
| Catherine Cukras, National Eye Institute |
| Bruce Drum, US Food and Drug Administration |
| Adam Dubis, Duke University |
| Alfredo Dubra, Medical College of Wisconsin |
| Jacque Duncan, University of California San Francisco |
| David Eveleth, CONNECT |
| Sina Farsiu, Duke University |
| R. Daniel Ferguson, Physical Sciences Inc. |
| Yale Fisher, VRM Consultants of New York |
| Anne Fulton, Harvard University |
| Kiyoko Gocho-Nakashima, Nippon Medical School Chiba Hokusoh Hospital |
| Jane Gwiazda, New England College of Optometry |
| Daniel Hammer, U.S. Food and Drug Administration |
| Masaaki Hanebuchi, NIDEK CO., LTD. |
| Jennifer Hunter, University of Rochester |
| Takeshi Kitamura, Canon U.S.A., Inc. |
| Giuseppe Lombardo, National Research Council (CNR) |
| Marco Lombardo, IRCCS Fondazione G.B. Bietti |
| Matthew McMahon, National Eye Institute |
| Michel Michaelides, Moorfields Eye Hospital |
| Toshifumi Mihashi, Tokyo Institute of Technology |
| Donald Miller, Indiana University |
| Jessica Morgan, University of Pennsylvania |
| Matthew Muller, Aeon Imaging, LLC |
| Lisa Neuhold, National Institutes of Health |
| Utsunomiya Norihiko, Canon Inc. |
| Sotaro Ooto, Kyoto University Graduate School of Medicine |
| Richard Ornberg, NIBR-Research Imaging, Alcon Laboratories |
| Michel Paques, Quinze-Vingts Hospital |
| Sung Pyo Park, Columbia University Medical Center |
| Mark Pennesi, Casey Eye Institute |
| Michael Pircher, Medical University of Vienna |
| Jason Porter, University of Houston |
| Hope Queener, University of Houston |
| Austin Roorda, University of California Berkeley |
| Stephen Rose, Foundation Fighting Blindness |
| Richard Rosen, New York Eye and Ear Infirmary |
| Ethan Rossi, University of Rochester |
| Hendrik Scholl, Wilmer Eye Institute, Johns Hopkins University School of Medicine |
| Ronald Schuchard, Stanford University/QLT Inc. |
| Drew Scoles, University of Rochester |
| William Seiple, Lighthouse International |
| Paul Seiving, National Eye Institute |
| Hongxin Song, University of Rochester |
| Kimberly Stepien, Medical College of Wisconsin |
| Yusufu Sulai, University of Rochester |
| Jennifer Sun, Joslin Diabetes Center, Harvard Medical School |
| Johnny Tam, Institut de Ciencies Fotoniques |
| John Todhunter, SRS International Corporation |
| Rishard Weitz, New York Eye & Ear Infirmary |
| Carol Westall, SickKids Hospital |
| David Williams, University of Rochester |
| Wai Wong, National Eye Institute |
| Tom Wright, Hospital For Sick Children |
| Nagahisa Yoshimura, Kyoto University |
| Robert Zawadzki, University of California Davis |
| Yuhua Zhang, University of Alabama at Birmingham |
Attend an upcoming related topical meeting.
